Springer Nature OA
open access
Future Perspectives in MSC–EV-Based Cell-Free Therapy
This chapter explores future perspectives in MSC–EV-based cell-free therapy, focusing on precision medicine, bioengineering, and integration with artificial intelligence and omics technologies. It discusses emerging strategies for personalized therapy, advanced manufacturing, and clinical adoption.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies#859115
- Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors#979170
- Convergence of Nanotechnology and Artificial Intelligence: Revolutionizing Healthcare and Beyond#718361
- Engineered antigen presenting cells and uses thereof#260045
- Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia#886202
Record · ID 1317924
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive